10月16日,国外媒体报道称:美国总统特朗普称热门降糖药物司美格鲁肽在美国的价格可能降至每月仅150美元,比此前每月499美元价格降幅高达60%。此消息一出,引发资本市场震动。10月16日美股诺和诺德、礼来股价大幅下挫。根据美国白宫椭圆形办公室的新闻发布会的消息,司美格鲁肽的自付费用将降至150美元。不过,联邦医疗保险和医疗补助服务中心的穆罕默德·奥兹立即澄清称:“目前相关价格仍在进行中,双方尚未...
Source Link10月16日,国外媒体报道称:美国总统特朗普称热门降糖药物司美格鲁肽在美国的价格可能降至每月仅150美元,比此前每月499美元价格降幅高达60%。此消息一出,引发资本市场震动。10月16日美股诺和诺德、礼来股价大幅下挫。根据美国白宫椭圆形办公室的新闻发布会的消息,司美格鲁肽的自付费用将降至150美元。不过,联邦医疗保险和医疗补助服务中心的穆罕默德·奥兹立即澄清称:“目前相关价格仍在进行中,双方尚未...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.